# Baker Gordon Syndrome Natural History Study

> **NCT06399952** · — · RECRUITING · sponsor: **University of Missouri-Columbia** · enrollment: 50 (estimated)

## Conditions studied

- Rare Diseases
- Autism or Autistic Traits
- Development Delay
- SYT-SSX Fusion Protein Expression
- Sleep Disorder
- Epilepsy, Generalized
- Motor Delay

## Interventions

- **DIAGNOSTIC_TEST:** Brain Magnetic Resonance Imaging (MRI)
- **GENETIC:** Whole Genome Sequencing
- **OTHER:** Induced Pluripotential Stem Cells

## Key facts

- **NCT ID:** NCT06399952
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-30
- **Primary completion:** 2026-05-05
- **Final completion:** 2026-05-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06399952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06399952, "Baker Gordon Syndrome Natural History Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06399952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*